Please login to the form below
Amjevita
This page shows the latest Amjevita news and features for those working in and with pharma, biotech and healthcare.
Settlement clears path for Biogen, Samsung’s Humira biosimilar
Amgen’s agreement was slightly different in that US sales of its Amjevita biosimilar can start from January 31, and both deals include royalty payments to AbbVie, although the details of
Latest news
-
Novartis joins biosimilar Humira push in US
Novartis joins biosimilar Humira push in US. Pharma giant hopes its candidate will follow in the footsteps of Amgen’s Amjevita and BI’s Cyltezo. ... The biosimilar is vying to be the third copycat version of AbbVie’s Humira (adalimumab) in the big
-
AbbVie deal with Amgen sets biosimilar Humira launch dates
Amgen secured approval in Europe for its biosimilar under the Amgevita brand name in March and in the US as Amjevita a year ago, said that the drug will be one
-
Sandoz says Humira biosimilar clears clinical hurdle
the go-ahead for its product - known as Amjevita in the US market - in September 2016.
-
New EU and US approvals for Humira biosimilars
It is the second to claim marketing approval in the US market after Amgen's Amjevita (adalimumab-atto), which got the go-ahead in September 2016. ... AbbVie is claiming patent protection for Humira in the US out to 2022 and has already taken legal action
-
Amgen wins European approval for Humira biosimilar Amgevita
Amgen’s Humira biosimilar was approved last September in the US under the brand name Amjevita (adalimumab-atto), whose non-proprietary name follows January biosimilar guidance from the FDA for the
More from news
Approximately 2 fully matching, plus 7 partially matching documents found.
Featured jobs
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Business Unit Head, Medical Communications, London
-
Excellent package
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
Subscribe to our email news alerts
- Moving annual total (MAT)
- Brexit rebels win vote on European Medicines Agency alignment
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- MaxCyte gets green light for solid tumour cell therapy
- NHS England to Vertex: come clean on Orkambi offer
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Random42 win Creativity International Award for Scientific Animation
- Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
- Aurora partners with PIPHealth and taps into patient panels
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
- OUTiCO growth in multi-channel creates more job openings
PMHub
Digitas Health
Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
